Language selection

Search

Patent 2041348 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2041348
(54) English Title: COMPOSITION AND USE
(54) French Title: COMPOSITION ET UTILISATION DE CELLE-CI
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • A01N 43/78 (2006.01)
  • C09D 5/14 (2006.01)
(72) Inventors :
  • MORPETH, FRASER F. (United Kingdom)
(73) Owners :
  • MORPETH, FRASER F. (Not Available)
  • IMPERIAL CHEMICAL INDUSTRIES PLC (Not Available)
(71) Applicants :
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1991-04-26
(41) Open to Public Inspection: 1991-10-28
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
9009530.8 United Kingdom 1990-04-27

Abstracts

English Abstract



S 35718

ABSTRACT
"COMPOSITION AND USE"
A composition which contains a 4,5-polymethylene-4
-isothiazolin-3-one, and a defined isothiazolinone which is different
from the 4,5-polymethylene-4-isothiazolin-3-one and which can be a
4,5 optionally halogenated N-alkyl isothiazolin-3-one. The
compositions exhibit anti-microbial activity and certain combinations
are surprisingly effective against bacteria.


Claims

Note: Claims are shown in the official language in which they were submitted.



-15- S 35718/US
CLAIMS
1. A composition which comprises
a) at least one 4,5-polymethylene-4-isothiazolin-3-one or a
derivative thereof, and
b) at least one isothiazolin-3-one derivative which cloes not
contain a fused ring attached to the isothiazoline ring.

2. A composition as claimed in claim 1 wherein a) is at least
one compound of the general formula:

Image
wherein

R1 and R2 together represent a polymethylene chain having 3
or 4 carbon atoms, or a polymethylene chain having 3 or 4 carbon
atoms substituted by a lower alkyl radical having from 1 to 4 carbon
atoms;
R3 represents hydrogen, linear or branched alkyl having up to 12
carbon atoms, linear or branched alkyl having up to 3 carbon atoms
substituted by at least one hydroxyl group, an alkenyl group having
from 3 to 6 carbon atoms, a radical of the formula

Image



-16- S 35718
wherein
n is 0 or 1;
m is 1 or 2;
R4 represents hydrogen or alkyl having from 1 to 4 carbon atoms; and
R5 represents hydrogen, alkyl having from 1 to 4 carbon atoms, nitro,
trifluoromethyl or halogen, cycloalkyl having from 3 to 6 carbon
atoms, a radical of formula

Image

wherein R6 represents hydrogen, linear or branched alkyl
having up to 12 carbon atoms or a radical of formula

Image

as defined above, or a mineral or organic salt thereof.

3. A composition as claimed in claim 2 wherein a) is at least

Image

wherein t is 1 or 2.

4. A composition as clalmed in claim 3 wherein t is 1 and R3
is either hydrogen or alkyl.



-17- S 35718

5. A composition as claimed in any one of claims 1 to 4
wherein component a) is either 4,5-trimethylene-4-isothiazolln-3-one
or 2-methyl 4,5-trimethylene-4-isothiazolin-3-one.

6. A composition as claimed in any one of claims 1 to 5 where
component b) is at least one compound of general formula

Image

wherein
Y is a hydrogen atom, an alkyl, substituted alkyl, alkenyl,
alkynyl, cycloalkyl, aralkyl or aryl group; and

R7 is hydrogen, halogen or an alkyl group; and
R8 is hydrogen, halogen or an alkyl group.

7. A composition as claimed in claim 6 wherein Y is an alkyl
group containing from 1 to 18 carbon atoms.

8. A composition as claimed in claims 6 or 7 wherein Y is nn
alkyl group containing from 1 to 4 carbon atoms.

9. A composltion as claimed in any one of claims 6 to 8
wherein R7 and/or R8 is independently chlorine, bromine or alkyl
containing from 1l to 4 carbon atoms.



-18- S 35718

10. A composition as claimed in any one of claims 1 to 9
wherein component (b) is selected from 2-methyl isothiazolin-3-one,
5-chloro-2-methyl isothiazolin-3-one and 4,5 dichloro-2-methyl
isothiazolin-3-one either alone or in combination.

11. A composition as claimed in any one of claLms 1 to 10 which
comprises 2-methyl-4,5-trimethylene-4-isothiazolin-3-one together
with at least one of 2-methyl isothiazolin-3-one, 5-chloro-2-methyl
isothiazolin-3-one and 4,5-dichloro-2-methyl isothiazolin-3-one.

12. A composition as claimed in any one of claims 1 to 11 which
contains from one part by weight of component (a) or of component (h)
and correspondingly up to 1000 parts by weight of component (b) or of
component (a).

13. A composition as claimed in claim 12 which contains at
least one part by weight of one component, or mixture of components,
and not more than 100 parts by weight of the other component or
mixture of components.

14. A composition as claim in any one of claims 12 and 13 which
contains between 1 and 10 parts which is component (a) and between 10
and 1 parts which is component (b).

15. A composition as claimed in any one of claims 12 to 14
which contains between 1 and 5 parts of component (a) and between 5
and 1 parts which is component (b).

16. A composition as claimed in any one of claims 1 to 15
wherein the sum of the fractional inhibitory concentration of the
components is less than 0.7.


-19- S 35718

17. A composition as claimed in any one of claims 1 to 16 which
additionally includes a carrier.

18. A medium which is susceptible to attack by micro-organisms
and which contains from 0.00001 to 10% by weight of the medium of a
composition us claimed in any one of claims 1 to 16.

19. A medium as claimed in claim 18 which contains from 0.00002
to 1% by weight of the medium of the composition.

20. A medium as claimed in either claim 18 or claim 19 which
contains from 0.00002 to 0.01% by weight of the medium of the
composition.

21. A medium as claimed in any one of claims 18 to 20 which is
selected from a cooling water system, a paper mill liquor, a metal
working fluid, a geological drilling lubricant, a polymer emulsion, a
paint, a lacquer, a varnish, a hydrocarbon fluid, an adhesive, a
dyestuff or ink formulation, an agrochemical formulation, leather or
wood.

22. A paint medium as claimed in claim 21 which is an acrylic
latex.

23. A method for inhibiting the growth of micro-organisms on,
or in, a medium, which comprises treating the medium with a
composition as claimed in any one of claims 1 to 17.

24. A method for inhibiting the growth of micro-organisms on,
or in, a medium, which comprises treating the medium with component
(a) and component (b) sequentially,
wherein
a) is at least one 4,5-polymethylene-4-isothiazolin-3-one or a
derivative thereof, and
b) is at least one isothiazolin-3-one which does not contain a
fused ring attached to the isothiazoline ring.



-20- S 35718

25. A method as claimed in either claim 23 or claim 24 wherein
the medium which is treated is a cooling water system, a paper mill
liquor, a metal working fluid, a geological drilling lubricant, a
polymer emulsion, a paint, a lacquer, a varnish, a hydrocarbon fluid,
an adhesive, a dyestuff or ink formulation, an agrochemical
formulation, leather or wood.

26. A composition as claimed in claim 1 and substantially as
hereinbefore described with reference to the Example.

Description

Note: Descriptions are shown in the official language in which they were submitted.


3 ~ ~
-1- S 35718


COMPOSITION APID USE

The present invention relates to compositions which are
useful as industrial biocides.

Industrial biocides are useful to prevent industrial
spoilage, in particular that caused hy bacteria and fungi.
Industrial biocides find application in the preservation of paints,
latices, adhesives, leather, wood, metal working fluids and cooling
water.

One class of compound which can be used as an industrial
biocide is based on the isothiaæolinone structure. There are many
disclosures of isothiazolinone derivatives which are stated to have
useful biocidal properties. US Patent 3761488 discloses
isothiazolinGne deriva~ives in which alkyl, alkenyl, alkynyl,
cycloalkyl, aralkyl or aryl groups, which may optionally be
substituted, are attached to the nitrogen atom and the 4 and 5
positions are unsubstituted or are substituted with halogen or lower
alkyl groups. US Patent 4165318 discloses a solution of an
isothia~olin-3-one in a polar organic solvent, wherein the solution
also contains a stabilising amount of formaldehyde. Stabilisation
of similar compounds is also claimed in US Patent 4,067,878 where the
stabilising compound is a nitrite or nitrate of a metal cation.
British Patent Specification 2087388 discloses
4,5-polymethylene-4-isothia~olin-3-ones and derivatives thereof in
which the polymethylene chain has three or four carbon atoms.

Compounds and compositions of the foregoing types, and
related compounds of the same general type, are effective to a
varying degree, depending on the particular compound or composition,
against a range of bacteria and/or fungi. However, to reduce the
cost of using these compounds it is desirable to improve their
effectiveness as antimicrobial materials.




~ , " . '' ,

3 ~ ~

2- S 35718


Compositions have been proposed which contain more than one
compound which has antimicrobial properties. In general such
compositions show an aggregate of the properties of the co~pounds
present in the composition. Typically such compositions contain one
compound which e~hibits useful antibacterial properties together with
a different compGund which exhibits useful antifungal properties.

We have now found that certain compositions possess
surprisingly useful antimicrobial properties, especially
antibacterial properties.

Thus, according to the present invention there is provided a
composition which comprises

(a) at least one 4,5 polymethylene-4-isothiazolin-3-one or a
derivative thereof, and

(b) at least one isothiazolin-3-one derivative which does not
lS contain a fused ring attached to the isothiazole ring.

The 4,5 polymethylene-4-isothia~olin-3-one derivative which
is component a) of the composition is typically z compound of the
general formula I.

- R \ / O\
\ 3
) ~ N - R

~-Rl \S/

wherein:

Rl and R2 taken together represent A polymethylene chain,
having 3 or 4 carbon a~oms or a polymethylene chain having 3 or 4
carbon atoms s~bstituted by at least one lower alkyl rad:Lcal having
from 1 to 4 carbon atoms;

3 ~ $
3_ S 35718


R represents hydrogen; a linear or branched alkyl group
having from 1 to 12 carbon atoms; a linear or branched alkyl group
having from 1 to 3 carbon atoms substituted by one or more hydroxyl
groups; an alk~nyl group having from 3 to 6 carbon atoms; a radical
of the formula

(R5)m

(C~IR4)


wherein:

; n is 0 or 1;
m is 1 or 2;
R4 represents hydrogen or a lower alkyl group; and
R5 represents hydrogen, lower alkyl, nitro, trifluoromethyl
or halogen, preferably chlorine, bromine or iodine; cyclo alkyl
having from 3 to 6 carbon atoms; and a radical of formula
o




_ C - NHR

wherein

R6 represents hydrogen, linear or branched alkyl having
from 1 to 12 carbon atoms or a radical of the formula

(R5)~

-(CEIR4) ~

as defined above, and their salts with a mineral or organic
Acid.




:

3 ~ ~
~ S 35718


In a preferred embodiment of the invention the
4,5-polymethylene-4-isothiazolin-3-one can be represented by the
general formula II



(cH2~t C82 ) f \ N - R3 II

\ CH \ S /

wherein t is l or 2 and R3 is as defined above. These
compounds are, thus, derivatives of 4,5-trimethylene or
4,5-tetramethylene-4-isothia701in-3--ones.

R3, in formulae I and II, may be a linear or branched alkyl
group, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl,
tert-butyl, hexyl, octyl or dodecyl.

When R3 represents alkyl substituted by one or more
hydroxyl groups, this includes, for instance, hydroxymethyl,
2-hydroxyethyl, 2-hydroxypropyl and l,2 dihydroxy propyl.

As an example of alkenyl as represented by R3, ~here may be
mentioned allyl.

When K3 represents a radical of formula

(RS)m

-tCHR4)n ~

this can be, for example, phenyl, chlorophenyl, 2,4-dichlorophenyl,
benzyl, 4-chlorob~nzyl or 2,4-dichlorobenzyl.



- '
~ '

-5- S 35718


When R3 represents cycloalkyl havirlg from 3 to 6 carbon
atoms, this can be, for example, cyclopropyl, cyclobutyl, cyclopentyl
or cyclohexyl.

Finally, when R3 represents a radical of formula
o




Il 6
- C-NHR

it can be carbomoyl, N-methyl carbamoyl, N-ethylcarbamoyl,
N-isopropyl carbamoyl, N-propyl carbamoyl, N-phenyl carbamoyl,
N-cyclohexyl carbamoyl, N-butyl carbamoyl or N-octyl carba~oyl.

The tenm lower alkyl represented by R4 above includes
linear or branched alkyl chains containing up to 4 carbon atoms such
as methyl, ethyl, isopropyl, butyl and tertiary butyl.

As specific examples of compounds which may be used as
component (a) of the composition of the present invention, there may
be mentlonsd 2-methyl-4,5-trimethylene isothiazolin-3-one. (formula
II, in which t is 1 and R3 is methyl), and 4,5-trimethylene
lsothiazolin-3-one tformula II, in which t is 1 and R3 is hydrogen).
~;:
Component bj of the composition is an isothiazolin-3-one of
general formula III



~ / III
S




wherein

Y is a hydrogen atom, an alkyl, substitutsd alkyl, alkenyl,
alkynyl, cycloalkyl, aralkyl or aryl group;



:. . .


.: . . . .
,



-6- S 35718

R7 is hydrogen, halogen or an alkyl group; and

R8 is hydrogen, halogen or an alkyl group.

When Y is alkyl, it is preferably an alkyl group containing
from 1 to 18 carbon atoms and especially from 1 to 4 carbon atoms and
particularly a methyl group.

When Y is cycloalkyl, it is preferably a cycloalkyl group
containing from 3 to 12 carbon atoms and especially fro~ 3 to 8
carbon atoms and particularly a cyclohexyl group.

When Y is alkyl or aralkyl, it preferably contains up to 10
carbon atoms. The aryl groups, themselves, may also carry
substituents such as halogen, particularly chlorine, or alkyl or
alkoxy groups containing up to 4 carbon atoms such as methyl and
methoxy.

When R andlor R8 is halogen, it is particularly chlorine
or bromine, and when R7 andlor R3 is alkyl it is particularly an
alkyl group containing from 1 to 4 carbon atoms and especially
methyl.

Particularly important within this group of compounds are
those in which Y represents a linear or branched alkyl group
containing up to 8 carbon atoms and where R7 and R8 represent
independently hydrogen or chlorine. Thus, as specific examples of
compounds which may be used as componen~ ~b) of the composition of
the present invention, there may be mentioned 2~methyl
isothiazolin-3-one ~formula III, in which Y is methyl, R7 and R~ are
both hydrogen), 5-chloro-2-methyl
-lsothia7,01in-3-one ~formula III, in which Y is methyl, R7 is
chlorine and R8 is hydrogen) and 4,5 dichloro-2-methyl
-isothiazolin-3-one ~formula III, in which Y is methyl, R7 and R8 are
both chlorine). Such compounds may represent component b) ln the
comyosition of the present invention as individual chemical compounds
or they may be preseDt in combination.



: . : - ,.- ~,
, : ~

-7- S 35718

A particularly useful combination has been found to be one
comprising ~-methyl-l~,5-trimethylene-4-iso~hiazolin-3-one together
with at least one of 2-methyl isothiazolin-3-one, S-chloro-~-methyl
isothiazolin-3-one and 4,5-dichloro-~-methyl isothia~olin-3-one.

In various types of applications, it is ~requently
necessary or convenient to formulate the isothiazolin-3-one as
represented by formula III in solution, especially using water or
polar organic solvents such as alcohols. While such formulation has
no effect on the stability or function of isothiazolin-3-ones as
anti-microbial agents if used relatively quickly, extanded storage of
the formulated solutions, especially at elevated temperature, may
result in chemical decomposition of the isothiazolin-3-one, thus
leading to reduced biocidal effectiveness. Consequently, it is
common to stabilise such formulations by incorporating nitrite or
nitrate salts of metals. It is also possible to stabilise such
compounds in the presence of formaldehyde or compounds which release
formaldehyde.

When isothizolin-3-ones of the afore-mentioned structures
as represented by formulae I and III are used in aqueous solution,
their solubility may be improved by forming their salts with strong
organic and/or inorganic acids such as hydrochloric acid, sulphuric
acid, succinic and citric acids.

The relative proportions of the components o the
composltion can vary and compositions having useful properties can be
obtained which contain from one part by weight o~ component (a) or
component (b) and correspondingly up to 1000 parts by weight of
component (b) or component (a). The preferred proportions are
dependent on the compouncls used as component (a) and component (b),
and also ~he particular system in which the mixture ls to be used.
In general the composition contains at least l part by weight of one
component and not more than 100 parts by weight of the other
component.

Particularly preferred compositions are those were the
ratio of component (a) to component (h) is be~ween 1:10 and 10:1 and
preferably between 1:5 and S:l such as, Eor ex~mple, 1:1.




,
`


-8- S 35718

The compositions of the present invention have
antimicrobial properties. We have found that compositions in
accordance with the present invention are especially active against
bacteria. Furthermore, compositions in accordance with the presen~
invention are such that the sum of the fractional inhibitory
concentration (FIC) for all the components of the composition is less
than one and, with preferred compositions is less than 0.7.
Especially preferred compositions are those in which the sum of the
FIC for all the components of the composition is not more than 0.6.
The FIC is the ratio of the concentration of an individual component
to the minimum inhibitory concentration of that component. It will
be appreciated that if the value of the sum of the FIC for all the
components of the composition is less than one, the composition is
synergistic, the extent of synergy being indicated by the amount by
which the 9um of the E~'IC is below one. We have found that some
compositions in accordance with the present invention are such that
the sum of the FIC is less than 0.6.

The compositions of the present invention have antimicrobial
properties and are suitable for use as industrial bioc~des. They
exhibit good wet state preservation and hence may be used as a
cutting fluid preservative and also in cooling water applications.
They may be used to preserve industrially important formulations,
especially aqueous based formulations, which are used for coloration,
such as dyestuffs and printing inks. They may also be used in the
a~rochemical industries to preserve formulations such as herbicide
and pesticide flowables.

Still further important appllcations of the compositions of
the present invention include their use in hydrocarbon fluids such as
diesel fuels. They may also be incorporated into adhesives in order
to inhiblt microbial spoilage.

The preservation of wood and leather is yet another
important application of the compositions.

Especially important is the use of the composition of the
present invention in paints, particularly in aqueous based latices.

2~3~
_g_ S 35718

A particularly preferred use of ~he compositions of the
present invention is for the preservation of poly vinyl acrylate and
particularly acrylic latices, espPcially those whose p~ is above 7,
and more especially those containing ammonia or amines.

The materials which are component (a) and component (b) of
the composition of the present invention are soluble in many polar
solvents, although the solubility is dependent on the nature of the
particular compounds which are present in the composition. Ho~ever,
many of the compounds are soluble in water, alcohols, ethers, ~etones
and other polar solvents or mixtures thereof.

The compositions of the present invention may be used alone
as an antimicrobial material but may also be used in, or on, a
suitable carrier material.

Thus, as a further aspect of the present invention there is
provided a biocide composition comprising a carrier and an effective
amount of a composition of components (a) and (b) in accordance with
the invention.

The carrier is typically a material which shows little, if
any, antimicrobial activity and may be, or include~ a material which
is susceptible to the growth of micro-organisms, particularly
bacteria. The carrier is preferably a liquid medium and the biocide
composition may be a solution, suspension or emulsion of the
composition of components (a~ and (b) ln a liquid carrier. The
carrier may be water, ln which one or both oE components (a) and (b)
are soluble, or may be a liquid such as acetic acid, N,N-dimethyl-
formamide, propylene glycol, dimethyl sulphoxide or N-methyl-
2-pyrrolidone in which at least one, and preferably both, o
componerlts (a) and (b) are soluble. Alternatively, a mix~ure of
liquids may be used, one being a solvent for component (a) and
component (b) and the other being a non-solvent Eor both components,
snd using such a mixture the composition typically comprises sn
emulsion or droplets of a solution of components (a) and (b) in the
solvent therefor dispersed ln ~he non-solvent. If a suspension or
emulsion is used, this conveniently contAins a surface active agent




- '.: .`~. ' ' '~
:
.

2 ~ 3 l~ ~
-10- S 3571


which is effective to maintain the non-continuous phase as a
suspension or emulsion. Any surface active agent known for use in
biocide compositions may be used in such a system, for example
alkylene oxide adducts of fatty alcohols, alkyl phenols and amines
such as ethylene diamine.

Whereas it is advantageous in using the composition of the
present invention to add component (a) and component (b)
simultaneously, it will be appreciated that in certain circumstances
it may be beneficial to add cornponent (a) and component (b)
sequentially.

The amount of the composition which is present in the
biocide composition may be just sufficient to have an antimicrobial
effect or the composition may be present in a substantially greater
proportion. It will be appreciated that the biocide composition may
be provided as a concentrated solution which is subsequently diluted
for use as an anti~icrobial material. The higher concentrations of
the biocide composition are useful for example in the bulk
transportation of the composition. Thus, the amount of the
composition of components (a) and (b) which is present in the
biocide composition is typically in the range from 0.00001% up to 30
by weight of the biocide composition.

The composition of the present invention is especially
effective in providing anti-bacterial activity. Thus, the
compositions can be used for the treatment of various media to
inhibit the growth of micro-organisms.

As a furthar aspect of the present invention there is
provided a method for inhlbiting the growth o micro-organisms on, or
in, a medium which comprises treating the medium with a composition
of components (a) and (b) as hereinbefore defined.




,
'

2 ~ L~
~ S 35718


The composition can be used in conditions in which
micro-organisms grow and cause problems. Systems in which
micro-organisms cause problems include liquid, particularly aqueous,
systems such as coollng water liquors~ paper mill liquors, metal
working fluids, geological drilling lubricants, polymer emulsions and
surface coating compositions such as paints, varn~shes and lacquers
and also solid materials such as wood and leather. The composition
of thP present invention can be included in such materials to provide
an anti-microbial effect. The amount of the composition is
l¢ typically in the ran8e from 0.00001 up to lOZ, preferably 0.00002 up
to 5z and especially 0.00002 to 1% by weight of the composition
relative to the system to which it is added. In many cases,
microbial inhibition has been obtained with between 0.00002 and O.OlZ
by weight of the composition.

lS Components (a) and (b) of the composition of the present
invention may be the only antimicrobial compounds or may be used
together with ~urther compounds having antimicrobial characteristics.
The composition may contain more than one compound which is
component (a) together with one or more compound which is component
(b). Alternatively, a composition of components (a) and (b~ in
accordance with the present invention may be used together with one
or more known antimicrobial compounds. The use of a mixture of
anti-microbial compounds can provide a co~position having a broader
anti-microbial spectrum and hence one which is more generally
effective than the components thereof. The known antimicrobial may
be one possessing anti-bacterial, antl-fungal, anti-algal or other
antimicrobial characteristic. The mixture o the composition of the
present invention with other antimicrobial compounds typically
contains from 1 to 9gZ by weight, relative to the weight of total
antimicrobially active compounds, of the composition of components
(a) and (b), and particularly from 40 to 60Z by weight of the
composition of components (a) and (b).




.'.-: ,: ' ~ ' '

.

-12- ~34~


As examples of known antimicrobial compounds which may be
used, together with the composition of the present invention, there
may be mentioned quaternary ammonium compounds such as
diPthyldodecylbenzyl ammonium chloride; dimethyloctadecyl-
(dimethylbenzyl)ammonium chloride; dimethyldidecylammonium chl.oride;
dimethyldidodecylammonium chloride; trimethy-tetradecylammonium
chloride; benzyldimethyl(Cl2-C18 alkyl)ammonium chloride;
dichlorobenzyldimethyldodecylammonium chloride; hexadecylpyridinium
chloride; hexadecylpyridinium bromide; hexadecyltrimethylammonium
bromide; dodecylpyridinium chloride; dodecylpyridini~m bisulphate;
benzyldodecyl-bi~(beta-hydroxyethyljammonium chloride; dodecyl-
benzyltrimethylammonium chloride; benzyldimethyl(C12-C18 alkyl~
ammonium chloride; dodecyl.dimethylethyl ammonium ethylsulphate;
dodecyldimethyl-(l-naphthylmethyl)ammoni~ chloride; hexadecyl-
dL~ethylbenzyl ammonium chloride; dodecyldimethylbenzyl ammlonium
chloride and l-(3-chloroallyl)-3,5,7-triaza l-azonia-adamantane
chloride; urea derivatives such as 1,3-bis(hydroxymethyl)-
5,5-dimethylhydan~oin; bis(hydroxymethyl)urea; tetrakis(hydroxy-
methyl)acetylene diurea; l-(hydroxymethyl)-5,5-dime~hylhydantoin and
imidazolidinyl urea; amino compounds such as 1,3-bis~2-ethyl-
hexyl)-S-methyl-5-aminohexahydropyrimidine; hexamethylene tetra
amine; 1,3-bis(4-aminophenoxy)propane; and 2-[(hydroxymethyl)-
amino]ethanol; imidazole derivatives such as 1[2-(2,4 dichloro-
phenyl)-2-(2-propenyloxy)ethyl~ -imidazole; 2-(methoxycarbonyl-
amino)-benzimidazole; nitrile compounds such as 2,4,5,6-tetra-
chloroisophthalodinitrile and 1,2-dibromo-2,4-dicyanobutane;
thiocyanate derivatives such as methylene bis thiocyanate; tin
compounds or complexes such as tributyl~in-oxide, chlorlde,
naphthoate, benzoate or 2-hydroxybenzoate; thiaæole derivatives such
as 2--(thiocyanomethylthio)-benzthiazole; and mercaptobenzthiazole;
nitro compounds such as tris(hydroxymethyl)nitromethane; 5-bromo-
S-nitro-1,3-dioxane and 2-bromo-2-nitropropane-1,3-diol; aldehydes
and derivatives such as gluteraldehyde ~pentanedial)
p-chlorophenyl-3-iodopropargyl formaldehyde and g:Lyoxal; amides such
as chloracetamide; ~,N-bis(hydroxymethyl)chloracetamide;
N-hydroxymethyl-chloracetamide and dithio-2,2-bis(benzmethyl amide);




.

3 l~ ~
-13- S 3571


guanidine derivatives such as poly hexamethylene biguanide and
1,6 hexamet~ylene-bis[5-(4-chlorophenyl)biguanide]; thiones such as
3,5-dimethyltet~ahydro-1,3,5-2EI-thiodiazine-2-thione; triazine
derivatives such as hexahydrotriazine and 1,3,5-tri-(hydroxyethyl)-
1,3,5-hexahydrotriazine; oxazolidine and derivatives thereof such as
bis-oxazolidine; furan and derivatives thereof such as
2,5-dlhydro-2,5-dialkoxy-2,5-dialkylfuran; carboxylic acids and the
salts and esters thereof such as sorbic acid and the salts thereof
and 4-hydroxybenzoic acid and the salts and esters thereof; phenol
and derivatives thereof such as 5-chloro-2-(2,4-dichloro-
phenoxy)phenol; thio-bis(4-chlorophenol) and 2-phenylphenol;
sulphone derivatives such as diiodomethyl-paratolyl sulphone,
2,3,5,6 ~etrachloro-4-(methylsulphonyl) pyridine and
hexachlorodimethyl sulphone.

Further aspects of ~he present invention are described in
the following illustrative exa~tples.

In the following examples, compositions in accordance with
the present invention were subjected to evaluation of the
antmticrobial properties especially anti-bacterial properties~ of the
compositions. The evaluation was effected, under sterile conditions
throughout, as &etailed below.

Microbiolo~ical evaluation

The materials, or mixture of materials, to be tested were
added to a mltrient broth in amounts to give a clc~ired concentration
of the added material. The added materials were added at
concentrations from zero to above the minimum inhlbitory
concentration of the particular material In the mixtures, the
concentrations of each material were varied in a systematic fashion
to give a matrlx of mixtures o~ different relative proportions ancl
different total concentrations.




.
,
~ ~ .

s~


The effect on ~he inhibition of growth of bacteria was
investigated by inoculating each sample of broth with sufficient of
the test micro-organism to give about lO5 cells cm~3. The mixture
was incubated at 30C for 48 hours. At the end of the test period
the presence of turbidity in the broth indicated that growth of the
test micro-organism had occurred. A lack of turbidity was
indicative that no growth had occurred. The results were used to
draw an isobologram from which the sum of the fractional inhibitory
concentration for a mixture can be determined.

Example 1

The microbiological evaluation as described was carried out
using the bacterium, Escherichla coli. The composition tested was a
mixture of 2-methyl-4,5-trimethylene-4-isothiazolin-3-one and
5-chloro-2-methyl-isothiazolin-3-one.

An isobologram was drawn using concentrations of 0, 0.2,
0.5, 0.7, 0.9, l.l, l.4, l,6, l.8 and 2 microgram cm 3 of the
trimethylene-isothiazolinone and 0, 0.2, 0.5, 0.7, 0.9, l.l, l.~,
1.6, l.8 and 2 microgr~m cm~3 of the chloro isothiazolinone.

From the results obtained, it was found that the lowest sum
of the fractional inhibitory concentration was 0.54 which was
obtained with a mixture of 0.2 microgram cm~3 of the
2-methyl-4,5-trimethylene-4-isothiazolin-3-one and 0.2 microgram cm 3
of the S-chloro-2-methyl-isothiazolin 3~one. This may be contrasted
with the minimum inhibitory concentrations (MIC) for the two
individual compounds against the ~amo micro-organism which were found
to be 1.4 microgram cm~3 and 0.5 mlcrogram cm~3 respectively.




~ ,

. ~ .

Representative Drawing

Sorry, the representative drawing for patent document number 2041348 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(22) Filed 1991-04-26
(41) Open to Public Inspection 1991-10-28
Dead Application 1994-10-26

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1991-04-26
Registration of a document - section 124 $0.00 1991-10-23
Maintenance Fee - Application - New Act 2 1993-04-26 $100.00 1993-03-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MORPETH, FRASER F.
IMPERIAL CHEMICAL INDUSTRIES PLC
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1991-10-28 1 21
Claims 1991-10-28 6 153
Abstract 1991-10-28 1 15
Cover Page 1991-10-28 1 19
Description 1991-10-28 14 568
Fees 1993-03-26 1 49